Borregaard opens cGMP pilot plant

Published: 1-Feb-2003


Borregaard's fine chemicals business has expanded its operations in Sarpsborg in Norway with the addition of a new research and pilot plant. The cGMP plant, which cost NOK40m (€5.5m), is part of the company's strategy to develop advanced intermediate products and active pharmaceutical ingredients (APIs).

The pilot plant is used to scale up, test and modify processes from development in the laboratory to the final production process in the factory. It is equipped with six reactors and associated purification equipment, including distillation columns and four filters, one of which is isolated in a separate end room. The inauguration of the new plant has tripled the company's pilot plant capacity and created six jobs.

Borregaard has intensified significantly research activities in several of its businesses in recent years, and its fine chemicals business, which targets mainly the pharmaceutical sector, now employs more than 40 researchers in Norway, Italy and the US.

You may also like